Zhu Rongfei, Liu Guanghui, Li Wenjing, Wang Zhongxi, Chen Huan, Zhang Wei
Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Sep;22(17):780-2, 784.
To investigate the expression of costimulatory molecules CD28/B7 and CD40/CD40L in T and B lymphocytes as well as its relations with total IgE (TIgE), eosinophil cationic protein (ECP) in serum and nasal allergic symptoms in patients with allergic rhinitis (AR). The effect of specific immunotherapy (SIT) on them were also investigated.
Thirty allergic allergic rhinitis patients were chosen as observation group, and 30 healthy patients as control group. Cytofluorometric analysis was used to compare the expression level of CD28/B7-1, B7-2 and CD40/CD40L on T cells and B cells in the two groups. The relationship between the CD28/ B7-1, B7-2 and CD40/CD40L expression level and serum Total IgE, ECP level were analyzed.
The expression level of CD28/B7-2 and CD40/CD40L on T cells and B cells in allergic rhinitis patients were significantly higher than in the healthy, and serum level of TIgE has a positive relationship with the expression level of CD40L on T cells. ECP has a positive relationship with the expression level of B7-2 on B cells. The expression level of B7-1 showed no significant difference between the two groups. After specific immunotherapy for 6 months, the expression level of CD28/B7-2 and CD40/CD40L on T cells and B cells were decreased in allergic rhinitis patients but still higher than in healthy.
The upregulated level of costimulatory molecules CD28/B7-2 and CD40/ CD40L on T cells and B cells may play an important role in the pathogenesis of allergic rhinitis, specific immunotherapy can downregulate the expression level of CD28/B7-2 and CD40/CD40L, and decrease the serum level of TIgE, it may be a possible mechanism in the treatment of allergic rhinitis.
探讨共刺激分子CD28/B7和CD40/CD40L在变应性鼻炎(AR)患者T、B淋巴细胞中的表达及其与血清总IgE(TIgE)、嗜酸性粒细胞阳离子蛋白(ECP)水平及鼻部变应症状的关系,并观察特异性免疫治疗(SIT)对其的影响。
选取30例变应性鼻炎患者作为观察组,30例健康者作为对照组。采用细胞荧光分析技术比较两组T细胞和B细胞上CD28/B7-1、B7-2及CD40/CD40L的表达水平,并分析CD28/B7-1、B7-2及CD40/CD40L表达水平与血清TIgE、ECP水平的关系。
变应性鼻炎患者T细胞和B细胞上CD28/B7-2及CD40/CD40L的表达水平显著高于健康者,血清TIgE水平与T细胞上CD40L的表达水平呈正相关,ECP水平与B细胞上B7-2的表达水平呈正相关。两组B7-1的表达水平差异无统计学意义。变应性鼻炎患者经特异性免疫治疗6个月后,T细胞和B细胞上CD28/B7-2及CD40/CD40L的表达水平降低,但仍高于健康者。
T细胞和B细胞上共刺激分子CD28/B7-2及CD40/CD40L表达上调可能在变应性鼻炎发病机制中起重要作用,特异性免疫治疗可下调CD28/B7-2及CD40/CD40L的表达水平,并降低血清TIgE水平,这可能是其治疗变应性鼻炎的机制之一。